Building Competency in Diabetes Education THE ESSENTIALS

TREATMENT MODALITIES: PHARMACOLOGICAL THERAPIES | 6-127

47. Neumiller JJ, Odegard PS, White JR, et al. Looking to the future: Focus on DPP-4 inhibitors for the treatment of type 2 diabetes and emerging therapies. Diabetes Educ 2008;34:183- 200. 48. Cornell S. Differentiating among incretin therapies: A multiple-target approach to type 2 diabetes. J Clin Pharm Ther 2012;37:510-24. 49. Lovshin JA. Glucagon-like peptide-1 receptor agonists: A class update for treating type 2 diabetes. Can J Diabetes 2017:41:524-35. 50. Ahren B. The future of incretin-based therapy: Novel avenues-novel targets. Diabetes Obes Metab 2011;13(Suppl. 1):158-66. 51. Goldenberg M. Management of unmet needs in type 2 diabetes: The role of the incretin agents. Can J Diabetes 2011;35:518-27. 52. Merck & Co. Inc. Januvia [prescribing information]. Whitehouse Station: Merck & Co, 2007. 53. Ratner R. Incretin-based therapies for type 2 diabetes: Clinical utility. Endocrinol Metab Clin North Am 2006;35(Suppl 1):12-6. 54. Bristol - Myers Squibb Canada. Onglyza product monograph. Montreal: Bristol-Myers Squibb Canada, 2013. 55. Boehringer Ingelheim (Canada) Ltd. Trajenta product monograph. Burlington: Boehringer Ingelheim (Canada), 2013. 56. Lyseng-Williamson KA. Sitagliptin. Drugs. 2007;67:587-97. 57. Merck Company Inc. Januvia product monograph. Kirkland: Merck, 2013. 58. American Diabetes Association. 11. Older Adults: Standards of Medical Care in Diabetes- 2018. Diabetes Care 2018;41(Suppl. 1):S119- S125. 59. Papadakis MA, McPhee SJ, Rabow MW. Current Medical Diagnosis & Treatment 2019, 58th ed. USA: McGraw-Hill Education, 2019. 60. Novo Nordisk Canada Inc. Victoza product monograph. Mississauga: Novo Nordisk Canada, 2017. 61. Eli Lilly Canada Inc. Trulicity product monograph. Toronto: Eli Lilly Canada, 2018. 62. AstraZeneca Canada Inc. Byetta product monograph. Mississauga: AstraZeneca Canada, 2014. 63. Sanofi-Aventis Canada Inc. Adlyxine product monograph. Laval: Sanofi-Aventis Canada, 2017.